Parallel Advisors’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $636 | Buy |
+71
| New | +$566 | ﹤0.01% | 3629 |
|
|
2025
Q4 | – | Sell |
-468
| Closed | -$2.67K | – | 3757 |
|
|
2025
Q3 | $2.67K | Hold |
468
| – | – | ﹤0.01% | 2978 |
|
|
2025
Q2 | $2.36K | Sell |
468
-44
| -9% | -$236 | ﹤0.01% | 3000 |
|
|
2025
Q1 | $3.32K | Hold |
512
| – | – | ﹤0.01% | 2820 |
|
|
2024
Q4 | $3.76K | Hold |
512
| – | – | ﹤0.01% | 2744 |
|
|
2024
Q3 | $3.83K | Sell |
512
-265
| -34% | -$2.3K | ﹤0.01% | 2709 |
|
|
2024
Q2 | $6.92K | Sell |
777
-74
| -9% | -$710 | ﹤0.01% | 2440 |
|
|
2024
Q1 | $8.62K | Hold |
851
| – | – | ﹤0.01% | 2368 |
|
|
2023
Q4 | $8.56K | Buy |
851
+352
| +71% | +$3.22K | ﹤0.01% | 2347 |
|
|
2023
Q3 | $4.68K | Sell |
499
-5
| -1% | -$71 | ﹤0.01% | 2520 |
|
|
2023
Q2 | $12.4K | Sell |
504
-73
| -13% | -$1.83K | ﹤0.01% | 2084 |
|
|
2023
Q1 | $13.4K | Buy |
577
+567
| +5,670% | +$14.5K | ﹤0.01% | 2015 |
|
|
2022
Q4 | $253 | Sell |
10
-7
| -41% | -$172 | ﹤0.01% | 3155 |
|
|
2022
Q3 | $0 | Sell |
17
-6
| -26% | -$153 | ﹤0.01% | 3538 |
|
|
2022
Q2 | $1K | Buy |
23
+13
| +130% | +$304 | ﹤0.01% | 2877 |
|
|
2022
Q1 | $0 | Sell |
10
-44
| -81% | -$1.3K | ﹤0.01% | 3306 |
|
|
2021
Q4 | $2K | Sell |
54
-20,725
| -100% | -$812K | ﹤0.01% | 2770 |
|
|
2021
Q3 | $904K | Sell |
20,779
-10,383
| -33% | -$450K | 0.04% | 272 |
|
|
2021
Q2 | $1.47M | Buy |
31,162
+22,364
| +254% | +$1.02M | 0.06% | 198 |
|
|
2021
Q1 | $451K | Sell |
8,798
-4,787
| -35% | -$258K | 0.02% | 371 |
|
|
2020
Q4 | $364K | Hold |
13,585
| – | – | 0.02% | 398 |
|
|
2020
Q3 | $466K | Buy |
13,585
+12,528
| +1,185% | +$539K | 0.03% | 322 |
|
|
2020
Q2 | $43K | Buy |
+1,057
| New | +$35.5K | ﹤0.01% | 1110 |
|
Other funds holding VIR
AVM
SIAU
VPM
GP
VCM
ACM